Investor desk
Watch for partnership announcements between health systems and specialty pharma; PBM-adjacent vendors (data, AI, hub services) often preview enterprise deals here.
← Back to Events
Tier 1 Global Networking: High GENERAL CONCLUDED
THMA CPE Circle — 2026 — Fort Lauderdale, USA
Explore the top pharmacy conferences in 2026. Get executive insights on 340B reform, IRA drug pricing, and AI adoption from Asembia, ASHP, and THMA forums.
300+ Attendees
1 Presentations
1 Companies
Presentation data updated Jun 16, 2026, 9:36 PM UTC
Why This Event Matters
Explore the top pharmacy conferences in 2026.
Industry impact
Explore the top pharmacy conferences in 2026.
Market implications
Expect signals on PBM–provider alignment, biosimilar tendering, and ambulatory margin recovery as systems negotiate manufacturer contracts.
Regulatory implications
FDA real-world evidence pilots and 340B policy uncertainty shape how pharmacy leaders justify evidence-generation and access investments.
Investor implications
Watch for partnership announcements between health systems and specialty pharma; PBM-adjacent vendors (data, AI, hub services) often preview enterprise deals here.
Competitive implications
Competitive positioning among top general players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.
Event Significance
Tier-1 industry catalyst
56 /100 composite
THMA CPE Circle is a targeted general forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: downstream media and analyst follow-through.
- Media coverage 20/20
High follow-on media and sell-side note volume expected within 24–48h of key sessions.
- Speaker quality 14/20
Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.
- Pipeline relevance 0/20
Early science or services-focused — lower near-term PDUFA linkage.
- Historical influence 20/20
Prior editions moved stock prices and label expansions — expect similar volatility windows.
- Company participation 2/20
Smaller exhibitor set — focus on disclosed presenters rather than floor traffic.
Nova Pharma Intelligence · Analyst desk
Key Takeaways
- THMA carries 1 tracked presentations — map against peer readouts at THMA CPE Circle.
- Watch for partnership announcements between health systems and specialty pharma; PBM-adjacent vendors (data, AI, hub services) often preview enterprise deals here.
- FDA real-world evidence pilots and 340B policy uncertainty shape how pharmacy leaders justify evidence-generation and access investments.
Timeline & Milestones
- Pre-event intelligence Complete
1 presentations tracked — Key Data and Companies hubs live.
- Conference opens May 11, 2026 Complete
Live readouts, late-breakers, and partnership announcements.
- Live coverage window Complete
4 Nova articles linked — see Coverage & Analysis.
- Conference closes May 13, 2026 Complete
Post-event recap, competitive takeaways, and trial updates.
Investors & analysts
Executive Summary
C-level briefExplore the top pharmacy conferences in 2026.
Primary audience: Investors & analysts
Analyst Watch
Regulatory affairs
FDA real-world evidence pilots and 340B policy uncertainty shape how pharmacy leaders justify evidence-generation and access investments.
Competitive intelligence
Competitive positioning among top general players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.
vs. Prior Editions
| Edition | Presentations | Companies |
|---|---|---|
| THMA CPE Circle (current) | 1 | 1 |
| THMA Pharmacy Growth (2026) | 6 | 0 |
| THMA Oncology Forum (2026) | 4 | 0 |
Most Anticipated Presentations
Full data hub → OTHER May 11
AI adoption and workflow integration in healthcare systems
Competitive Landscape
Company map →Competitive positioning among top general players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.
Companies to Watch
All companies →Coverage & Analysis
4 articlesRelated News & Research
Research hub →Event Intelligence Summary
Standalone summaries for THMA CPE Circle — optimized for research and AI retrieval.
Executive Summary
Explore the top pharmacy conferences in 2026.
Analyst View
Explore the top pharmacy conferences in 2026.
Investor View
Watch for partnership announcements between health systems and specialty pharma; PBM-adjacent vendors (data, AI, hub services) often preview enterprise deals here.
BD View
BD teams should prioritize networking with presenting companies and services vendors at THMA CPE Circle, focusing on general partnership and licensing opportunities.
Key Facts
- Event
- THMA CPE Circle
- Focus
- general
- Region
- US Americas
- Attendance
- 300+
Ask Nova AI
AI-assisted answers grounded in NovaPharmaNews intelligence
Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.
Frequently Asked Questions
What is THMA CPE Circle?
THMA CPE Circle is a general industry conference bringing together executives, clinical leaders, and investors to discuss pipeline, regulatory, and commercial strategy.
Who attends THMA CPE Circle?
Typical attendees include pharma executives, BD teams, investors, regulatory affairs professionals, and clinical operations leaders focused on general.
Why is THMA CPE Circle important?
THMA CPE Circle influences partnership timing, pipeline prioritization, and policy debates that affect general markets for the next 12–18 months.
When is THMA CPE Circle?
THMA CPE Circle takes place on the scheduled dates.
Where is THMA CPE Circle held?
THMA CPE Circle is held in the listed venue.
How many attendees does THMA CPE Circle attract?
THMA CPE Circle typically draws 300+ attendees from across the general ecosystem.
What companies participate at THMA CPE Circle?
1+ companies present data or participate in programming at THMA CPE Circle, spanning large pharma, biotech, and services vendors.
What should investors watch at THMA CPE Circle?
Investors should track partnership announcements, pipeline readouts, M&A signals, and management commentary on general catalysts during and after THMA CPE Circle.
What BD opportunities exist at THMA CPE Circle?
BD teams use THMA CPE Circle for licensing discussions, co-development talks, and vendor selection across general — especially in networking sessions and satellite meetings.
How does THMA CPE Circle compare with other pharma conferences?
THMA CPE Circle is a tier-1 global congress for general — compare speaker quality, company participation, and historical deal flow with peer events in the same therapeutic or commercial vertical.
How do I get NovaPharmaNews coverage of THMA CPE Circle?
NovaPharmaNews publishes pre-event briefs, live coverage, and post-event analysis for THMA CPE Circle. Subscribe to event alerts on this page for breaking updates.